APA (7th ed.) Citation

Falahatgaroshibi, D., Baixauli-Martín, J., Burguete, M. C., López-Morales, M. A., Aliena-Valero, A., Peris, J. E., & Salom, J. B. (2026). The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke. Pharmaceuticals (14248247), 19(3), 431. https://doi.org/10.3390/ph19030431

Chicago Style (17th ed.) Citation

Falahatgaroshibi, Dianoush, Júlia Baixauli-Martín, María C. Burguete, Mikahela A. López-Morales, Alicia Aliena-Valero, José E. Peris, and Juan B. Salom. "The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke." Pharmaceuticals (14248247) 19, no. 3 (2026): 431. https://doi.org/10.3390/ph19030431.

MLA (9th ed.) Citation

Falahatgaroshibi, Dianoush, et al. "The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke." Pharmaceuticals (14248247), vol. 19, no. 3, 2026, p. 431, https://doi.org/10.3390/ph19030431.